KLRC1 and neoplasm: The inhibitory ligands PD-L1, HLA-E, and MHC-I are of particular importance in mediating NK cell killing of tumor cells by interacting with their respective receptors—PD-1, CD94/NKG2A, and KIRs—on the surface of the NK cells [14,34,35].